ORMP
Price
$2.30
Change
-$0.01 (-0.43%)
Updated
Apr 24 closing price
Capitalization
93.96M
33 days until earnings call
XBIT
Price
$2.96
Change
-$0.20 (-6.33%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
90.24M
12 days until earnings call
Ad is loading...

ORMP vs XBIT

Header iconORMP vs XBIT Comparison
Open Charts ORMP vs XBITBanner chart's image
Oramed Pharmaceuticals
Price$2.30
Change-$0.01 (-0.43%)
Volume$24.56K
Capitalization93.96M
XBiotech
Price$2.96
Change-$0.20 (-6.33%)
Volume$462
Capitalization90.24M
ORMP vs XBIT Comparison Chart
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. XBIT commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Buy and XBIT is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ORMP: $2.30 vs. XBIT: $2.96)
Brand notoriety: ORMP and XBIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 20% vs. XBIT: 144%
Market capitalization -- ORMP: $93.96M vs. XBIT: $90.24M
ORMP [@Biotechnology] is valued at $93.96M. XBIT’s [@Biotechnology] market capitalization is $90.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileXBIT’s FA Score has 1 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • XBIT’s FA Score: 1 green, 4 red.
According to our system of comparison, both ORMP and XBIT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 6 TA indicator(s) are bullish while XBIT’s TA Score has 5 bullish TA indicator(s).

  • ORMP’s TA Score: 6 bullish, 4 bearish.
  • XBIT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ORMP and XBIT are a good buy in the short-term.

Price Growth

ORMP (@Biotechnology) experienced а +6.98% price change this week, while XBIT (@Biotechnology) price change was +0.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

ORMP is expected to report earnings on Aug 13, 2025.

XBIT is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($94M) and XBIT($90.2M) have the same market capitalization . ORMP YTD gains are higher at: -4.959 vs. XBIT (-25.063). ORMP has higher annual earnings (EBITDA): 9.44M vs. XBIT (-43.6M). XBIT has more cash in the bank: 183M vs. ORMP (142M). ORMP has less debt than XBIT: ORMP (429K) vs XBIT (10M). ORMP (0) and XBIT (0) have equivalent revenues.
ORMPXBITORMP / XBIT
Capitalization94M90.2M104%
EBITDA9.44M-43.6M-22%
Gain YTD-4.959-25.06320%
P/E Ratio20.91N/A-
Revenue00-
Total Cash142M183M78%
Total Debt429K10M4%
FUNDAMENTALS RATINGS
ORMP vs XBIT: Fundamental Ratings
ORMP
XBIT
OUTLOOK RATING
1..100
1121
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8091
PRICE GROWTH RATING
1..100
7087
P/E GROWTH RATING
1..100
405
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (67) in the Pharmaceuticals Other industry is in the same range as XBIT (76) in the Biotechnology industry. This means that ORMP’s stock grew similarly to XBIT’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as XBIT (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to XBIT’s over the last 12 months.

ORMP's SMR Rating (80) in the Pharmaceuticals Other industry is in the same range as XBIT (91) in the Biotechnology industry. This means that ORMP’s stock grew similarly to XBIT’s over the last 12 months.

ORMP's Price Growth Rating (70) in the Pharmaceuticals Other industry is in the same range as XBIT (87) in the Biotechnology industry. This means that ORMP’s stock grew similarly to XBIT’s over the last 12 months.

XBIT's P/E Growth Rating (5) in the Biotechnology industry is somewhat better than the same rating for ORMP (40) in the Pharmaceuticals Other industry. This means that XBIT’s stock grew somewhat faster than ORMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPXBIT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
68%
Declines
ODDS (%)
Bearish Trend 8 days ago
82%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PKKFF0.02N/A
+26.04%
TENET FINTECH GROUP INC.
SHECY13.910.67
+5.06%
Shin-Etsu Chemical Co., Ltd.
CABJF136.821.07
+0.79%
Carlsberg AS
WTBDY8.71-0.04
-0.46%
Whitbread Plc
SYAAF0.14N/A
-1.93%
Syrah Resources Ltd.

XBIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIT has been loosely correlated with GBIO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIT jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIT
1D Price
Change %
XBIT100%
-6.33%
GBIO - XBIT
40%
Loosely correlated
-6.62%
NAUT - XBIT
40%
Loosely correlated
-3.92%
ABOS - XBIT
37%
Loosely correlated
+7.84%
GLSI - XBIT
37%
Loosely correlated
+5.99%
ORMP - XBIT
36%
Loosely correlated
-0.43%
More